Skip to main content

Table 4 Number (percentage) of patients with diabetes having data recorded for each of the 12 indicators in 2006 and 2009, and relative increase (relative risk, RR, with 95% CI) in the proportion of patients with recorded data in 2009 with respect to 2006

From: Data collection of patients with diabetes in family medicine: a study in north-eastern Italy

 

Performance indicator

2006 (N = 18,507)

2009 (N = 20,744)

2009 vs. 2006

2009 vs. 2006

n (%)

n (%)

crude

RR (95% CI)

adjustedc

RR (95% CI)

a

Blood pressureb

1267 (6.8%)

1470 (7.1%)

1.04 (0.97, 1.12)

0.91 (0.85, 0.98)

b

BMIa

4665 (25.2%)

6126 (29.5%)

1.27 (1.23, 1.32)

1.17 (1.14, 1.21)

c

Smoking habitsa

730 (3.9%)

1034 (5.0%)

1.34 (1.21, 1.47)

1.25 (1.14, 1.37)

d

Total cholesterola

5664 (30.6%)

8726 (42.1%)

1.37 (1.33, 1.41)

1.27 (1.23, 1.30)

e

LDLa

2427 (13.1%)

3829 (18.5%)

1.37 (1.30, 1.44)

1.21 (1.16, 1.27)

f

Microalbuminuriaa

1093 (5.9%)

3438 (16.6%)

2.69 (2.41, 3.02)

2.33 (2.11, 2.57)

g

Creatininea

5482 (29.6%)

8376 (40.4%)

1.36 (1.31, 1.40)

1.26 (1.22, 1.29)

h

Creatinine clearancea

173 (0.9%)

623 (3.0%)

2.90 (2.40, 3.51)

2.27 (1.90, 2.71)

i

Glycated haemoglobinb

200 (1.1%)

453 (2.2%)

2.03 (1.70, 2.42)

1.60 (1.34, 1.90)

j

Foot examinationa

32 (0.2%)

194 (0.9%)

6.18 (3.70, 10.33)

4.87 (2.97, 7.99)

k

Eye examinationa

2148 (11.6%)

3593 (17.3%)

1.53 (1.45, 1.62)

1.30 (1.24, 1.37)

l

Urine testa

4830 (26.1%)

7461 (36.0%)

1.36 (1.32, 1.41)

1.28 (1.24, 1.32)

  1. BMI body mass index, LDL low-density lipoprotein
  2. a≥ 1 registration/year
  3. b≥ 4 registrations/year
  4. cAdjusted for patient’s sex, age, antidiabetic therapy, other therapy